Officials at Lonza say they will invest in additional bioconjugation capabilities in Visp, Switzerland. The expansion will add two multipurpose 1,200L manufacturing suites and manufacturing-related ...

Lonza has expanded beyond its Swiss roots to become one of the world’s largest pharmaceutical services firms, but as two new announcements show, its site in Visp, Switzerland, remains at its core.

New companies sometimes take years to get enough momentum to support an expansion. Ten23 health is not one of them. With today’s announcement of plans for a new facility, the CDMO is expanding twice ...

Ten23 health, a CDMO that launched just six months ago, continues to expand (PDF) its manufacturing facility in Visp, Switzerland. The contract drug manufacturer will add an additional 1,000 square ...

Click to open image viewer. Landscape and architecture sketch showing a view of multi-storied buildings in the town of Visp, in Switzerland's Rhone Valley. In the middle distance, beyond a stream with ...

This media is in the public domain (free of copyright restrictions). You can copy, modify, and distribute this work without contacting the Smithsonian. For more information, visit the Smithsonian's ...